Senores Pharmaceuticals Approves Allotment of 11.7 Lakh Warrants Convertible into Equity Shares

Senores Pharmaceuticals Limited has informed the Exchange about the outcome of its Board meeting held on March 28, 2026. The Board approved the allotment of 11,70,000 (Eleven Lakh Seventy Thousand) warrants convertible into equity shares to certain allottees. The warrants, carrying a right to subscribe to 1 (one) Equity Share, are priced at ₹812/- (Rupees Eight Hundred Twelve Only) per warrant, amounting to ₹ 95,00,40,000/- (Rupees Ninety Five Crore Forty Thousand Only). The allottees are required to pay ₹ 203/- (Rupees Two Hundred Three Only) as warrant subscription price, amounting to ₹23,75,10,000/- (Rupees Twenty Three Crores Seventy Five Lakhs Ten Thousand Only). The warrants allotted on preferential basis will be subject to lock-in restrictions as prescribed under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.